share_log

Arrowhead Pharmaceuticals(ARWR.US) Director Sells US$41,934.69 in Common Stock

moomoo News ·  May 6 18:48

$Arrowhead Pharmaceuticals (ARWR.US)$ Director Vakiener Victoria sold 1,799 shares of common stock on May 2, 2024 at an average price of $23.31 for a total value of $41,934.69.

1715035725445080132.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment